SEKINE Ikuo

Researcher's full information

Articles
  • Circulating endothelial cells in non-small cell lung cancer patients treated with carboplatin and paclitaxel
    Sekine Ikuo
    J Thorac Oncol/4(2)/pp.208-213, 2009-02
  • PhaseⅢtrial of palonosetron plus dexamethasone versus granisetron plus dexamethasone for the prevention of nausea and vomiting during cancer chemotherapy
    Sekine Ikuo
    Lancet Oncol/10(2)/pp.115-124, 2009-01
  • Genetic variations and haplotype structures of the glutathione S-transferase genes, GSTT1 and GSTM1, in a Japanese patient population
    Sekine Ikuo
    Drug Metab Pharmacokinet/24(1)/pp.118-126, 2009-01
  • Characteristics and outcomes of patients with advanced non-small-cell lung cancer who declined to participate in randomised clinical chemotherapy trials
    Sekine Ikuo
    Br J Cancer/100(7)/pp.1037-1042, 2009-03
  • A dose-finding and pharmacokinetic study of nedaplatin in elderly patients with advanced non-small cell lung cancer
    Sekine Ikuo
    Cancer Chemother Pharmacol 65:79-88, 2009/65(1)/pp.79-88, 2009-04
  • A Pharmacokinetic and Dose Escalation Study of Pegfilgrastim (KRN125) in Lung Cancer Patients with Chemotherapy-induced Neutropenia
    Sekine Ikuo
    Jpn J Clin Oncol/39(7)/pp.425-430, 2009-04
  • A phase II dose-ranging study of palonosetron, a 5HT3 receptor antagonist for the prevention of chemotherapy-induced nausea and vomiting (CINV), in Japanese patients receiving highly emetogenic chemotherapy
    Sekine Ikuo
    Ann Oncol/20(11)/pp.1860-1866, 2009-06
  • A phase II dose-ranging study of palonosetron, a novel 5HT3 receptor antagonist, in Japanese patients receiving moderately emetogenic chemotherapy, including anthracycline-cyclophosphamide based chemotherapy
    Sekine Ikuo
    Ann Oncol/20(11)/pp.1874-1880, 2009-07
  • Differences in the quality of information on the internet about lung cancer between the United States and Japan
    Sekine Ikuo
    J Thorac Oncol/4(7)/pp.829-833, 2009-07
  • Phase I study of TLR9 agonist PF-3512676 in combination with carboplatin and paclitaxel in patients with advanced non-small-cell lung cancer
    Sekine Ikuo
    Cancer Sci/101(1)/pp.188-195, 2009-09
  • Association of DNA repair gene polymorphisms with response to platinum-based doublet chemotherapy in patients with non-small-cell lung cancer
    Sekine Ikuo
    J Clin Oncol/28(33)/pp.4945-4952, 2010-10
  • Frequent ALK rearrangement and TTF-1/p63 co-expression in lung adenocarcinoma with signet-ring cell component
    Sekine Ikuo
    Lung Cancer/72(3)/pp.309-315, 2010-10
  • The usefulness of mutation-specific antibodies in detecting epidermal growth factor receptor mutations and in predicting response to tyrosine kinase inhibitor therapy in lung adenocarcinoma
    Sekine Ikuo
    Lung Cancer/73(1)/pp.45-50, 2010-12
  • Safety of BLP25 Liposome Vaccine (L-BLP25) in Japanese Patients with Unresectable Stage III NSCLC after Primary Chemoradiotherapy: Preliminary Results from a Phase I/II Study
    Sekine Ikuo
    Jpn J Clin Oncol/41(5)/pp.718-722, 2011-03
  • Amrubicin Monotherapy for Patients with Previously Treated Advanced Large-cell Neuroendocrine Carcinoma of the Lung
    Sekine Ikuo
    Jpn J Clin Oncol/41(7)/pp.897-901, 2011-06
  • Genetic variations of orosomucoid genes associated with serum alpha-1-acid glycoprotein level and the pharmacokinetics of paclitaxel in Japanese cancer patients
    Sekine Ikuo
    J Pharm Sci/100(10)/pp.4546-4559, 2011-06
  • Combination chemotherapy with carboplatin and paclitaxel for advanced thymic cancer
    Sekine Ikuo
    Jpn J Clin Oncol/41(8)/pp.1013-1016, 2011-08
  • Comprehensive histologic analysis of ALK-rearranged lung carcinomas
    Sekine Ikuo
    Am J Surg Pathol/35(8)/pp.1226-1234, 2011-08
  • Bright-field dual-color chromogenic in situ hybridization for diagnosing echinoderm microtubule-associated protein-like 4-anaplastic lymphoma kinase-positive lung adenocarcinomas
    Sekine Ikuo
    J Thorac Oncol/6(10)/pp.1677-1686, 2011-10
  • Figitumumab combined with carboplatin and paclitaxel in treatment-naïve Japanese patients with advanced non-small cell lung cancer
    Sekine Ikuo
    Invest New Drugs/30(4)/pp.1548-1556, 2012-08
  • Retrospective Analysis of Third-Line and Fourth-Line Chemotherapy for Advanced Non-Small-Cell Lung Cancer
    Sekine Ikuo
    Clin Lung Cancer/13(1)/pp.39-43, 2012-01
  • Pharmacokinetic and pharmacodynamic study on amrubicin and amrubicinol in Japanese patients with lung cancer
    Sekine Ikuo
    Cancer Chemother Pharmacol/69(4)/pp.861-869, 2012-04
  • Risk Factors for Treatment-Related Death Associated with Chemotherapy and Thoracic Radiotherapy for Lung Cancer
    Sekine Ikuo
    J Thorac Oncol/7(1)/pp.177-182, 2012-01
  • c-MET/phospho-MET protein expression and MET gene copy number in non-small cell lung carcinomas
    Sekine Ikuo
    J Thorac Oncol/7(2)/pp.331-339, 2012-02
  • Brain metastases after definitive concurrent chemoradiotherapy in patients with stage III lung adenocarcinoma: carcinoembryonic antigen as a potential predictive factor
    Sekine Ikuo
    Cancer Sci/103(4)/pp.756-759, 2012-04
  • more...